Press "Enter" to skip to content

New patent for Corcept Therap drug KORLYM

0
Copyright © DrugPatentWatch. Originally published at New patent for Corcept Therap drug KORLYM

Annual Drug Patent Expirations for KORLYM
Annual Drug Patent Expirations for KORLYM

Korlym is a drug marketed by Corcept Therap and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for KORLYM.

This drug has sixteen patent family members in nine countries.

The generic ingredient in KORLYM is mifepristone. One supplier is listed for this compound. Additional details are available on the mifepristone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Corcept Therap drug KORLYM
    Do NOT follow this link or you will be banned from the site!